Stem Cell Therapy Market

With over 280 therapies under evaluation, the stem cell therapy market

Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal […]

With over 280 therapies under evaluation, the stem cell therapy market Read More »

The stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis

With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism. In fact, recent studies suggest that mesenchymal stem cells have the potential to end the Coronavirus (COVID-19) pandemic.   Roots Analysis is pleased to

The stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis Read More »